Y7T

4-[(4-{[6-(4-acetylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]methyl}-1H-1,2,3-triazol-1-yl)methyl]-2-fluorobenzonitrile

Created:	2023-06-12
Last modified:	2024-12-18

Find Related PDB Entry
1 entries where Y7T is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	59
Chiral Atom Count	0
Bond Count	63
Aromatic Bond Count	17

2D diagram of Y7T

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-[(4-{[6-(4-acetylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]methyl}-1H-1,2,3-triazol-1-yl)methyl]-2-fluorobenzonitrile
Systematic Name (OpenEye OEToolkits)	4-[[4-[[6-(4-ethanoylpiperazin-1-yl)-4-oxidanylidene-quinazolin-3-yl]methyl]-1,2,3-triazol-1-yl]methyl]-2-fluoranyl-benzenecarbonitrile
Formula	C₂₅ H₂₃ F N₈ O₂
Molecular Weight	486.501
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CC(=O)N1CCN(CC1)c1ccc2N=CN(Cc3cn(Cc4cc(F)c(C#N)cc4)nn3)C(=O)c2c1
SMILES	CACTVS	3.385	CC(=O)N1CCN(CC1)c2ccc3N=CN(Cc4cn(Cc5ccc(C#N)c(F)c5)nn4)C(=O)c3c2
SMILES	OpenEye OEToolkits	2.0.7	CC(=O)N1CCN(CC1)c2ccc3c(c2)C(=O)N(C=N3)Cc4cn(nn4)Cc5ccc(c(c5)F)C#N
Canonical SMILES	CACTVS	3.385	CC(=O)N1CCN(CC1)c2ccc3N=CN(Cc4cn(Cc5ccc(C#N)c(F)c5)nn4)C(=O)c3c2
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC(=O)N1CCN(CC1)c2ccc3c(c2)C(=O)N(C=N3)Cc4cn(nn4)Cc5ccc(c(c5)F)C#N
InChI	InChI	1.06	InChI=1S/C25H23FN8O2/c1-17(35)31-6-8-32(9-7-31)21-4-5-24-22(11-21)25(36)33(16-28-24)14-20-15-34(30-29-20)13-18-2-3-19(12-27)23(26)10-18/h2-5,10-11,15-16H,6-9,13-14H2,1H3
InChIKey	InChI	1.06	FALMHAHJTTZSNA-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	172635976

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.